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Abstract: To compare the long-term effects of a very low carbo-
hydrate, high-protein, low saturated fat (LC) diet with a traditional high
unrefined carbohydrate, low-fat (HC) diet on markers of renal function
in obese adults with type 2 diabetes (T2DM), but without overt kidney
disease.
One hundred fifteen adults (BMI 34.6 4.3 kg/m2, age 58 7 years,
HbA1c 7.3 1.1%, 56 12mmol/mol, serum creatinine (SCr)
69 15mmol/L, glomerular filtration rate estimated by the Chronic
Kidney Disease Epidemiology Collaboration formula (eGFR
94 12mL/min/1.73m2)) were randomized to consume either an LC
(14% energy as carbohydrate [CHO< 50 g/day], 28% protein [PRO],
58% fat [<10% saturated fat]) or an HC (53% CHO, 17% PRO, 30% fatoakes, PhD, Jonat y, PhD,
rant D. Brinkworth, PhD
creatinine clearance (Cockcroft–Gault, Salazar–Corcoran) and albu-
min excretion rate (AER), were measured pre- and post-intervention.
Both groups achieved similar completion rates (LC 71%, HC 65%)
and reductions in weight (mean [95% CI]; 9.3 [10.6, 8.0] kg) and
blood pressure (6 [9, 4]/6[8, 5]mmHg), P 0.18. Protein
intake calculated from 24 hours urinary urea was higher in the LC than
HC group (LC 120.1 38.2 g/day, 1.3 g/kg/day; HC 95.8 27.8 g/day,
1 g/kg/day), P< 0.001 diet effect. Changes in SCr (LC 3 [1, 5], HC 1
[1, 3]mmol/L) and eGFR (LC 4 [6, 2], HC 2 [3, 0]mL/min/
1.73m2) did not differ between diets (P=0.25). AER decreased inde-
pendent of diet composition (LC 2.4 [6, 1.2], HC 1.8 [5.4,
1.8]mg/24 h, P= 0.24); 6 participants (LC 3, HC 3) had moderately
elevated AER at baseline (30–300mg/24 h), which normalized in 4
participants (LC 2, HC 2) after 52 weeks.
Compared with a traditional HC weight loss diet, consumption of
an LC high protein diet does not adversely affect clinical markers of
renal function in obese adults with T2DM and no preexisting kidney
disease.
(Medicine 94(47):e2181)
Abbreviations: AER = albumin excretion rate, CKD-EPI =
Chronic Kidney Disease Epidemiology Collaboration, CrC =
creatinine clearance, CVD = cardiovascular disease, DKD =
diabetic kidney disease, eGFR = estimated glomerular filtration
rate, FFM = fat free mass, HC diet = high carbohydrate, low-fat
diet, LC diet = very low carbohydrate, high protein, low saturated
fat diet, SCr = serum creatinine, T2DM = type 2 diabetes mellitus.
INTRODUCTION
C oncerns exist about the safety of protein-rich diets for renalfunction, particularly in populations with type 2 diabetes
mellitus (T2DM) who are at risk of nephropathy.1 Despite this,
very low carbohydrate, high protein, high fat (LC) diets are
rising in popularity amongst individuals with T2DM based on
growing evidence of their efficacy as a weight management
strategy to improve glycemic control and reduce cardiovascular
disease (CVD) risk.2 Few well-controlled, long-term studies
have systematically examined the effects of LC diets as part of a
comprehensive lifestyle modification program on renal function
in T2DM, limiting the applicability of LC diets as a diabetes
management strategy. This study compares the effects, after 1
year of consumption of a novel energy-restricted LC diet that
limits saturated fat, with an energy-matched traditional high, low-fat (HC) diet whilst undertaking a
gram, on renal function in obese adults
ut diabetic kidney disease (DKD).
www.md-journal.com | 1
MATERIALS AND METHODS
Participants and Study Design
Enrollment criteria, study design, and the primary study
outcomes have been previously described.2 Briefly, 115 adults
with T2DM and without overt kidney disease (57% male
(meanSD) BMI 34.6 4.3 kg/m2, age 58 7 years, HbA1c
7.3 1.1%, 56 12mmol/mol, serum creatinine (SCr)
69 15mmol/L, glomerular filtration rate estimated by the
Chronic Kidney Disease Epidemiology Collaboration formula
(eGFR-CKD-EPI) 94 12mL/min/1.73m2) were recruited by
public advertisement. Exclusion criteria were type-1 diabetes;
preexisting renal disease (eGFR< 60mL/min/1.73m2, elevated
SCr> 120mmol/l, and/or albumin excretion rate
(AER)> 300mg/24 h); abnormal liver function; any significant
endocrinopathy (other than stable treated thyroid disease);
history of malignancy, respiratory, gastrointestinal, or CVD;
pregnancy/lactation; history of/or current eating disorder or
smoking. The study was approved by the Human Research
Ethics Committees of the Commonwealth Scientific and Indus-
trial Research Organisation and the Universities of Adelaide and
South Australia. All participants gave written informed consent.
In a parallel design, participants were randomized to
consume either a hypocaloric (500–1000 kcal/day deficit) LC
diet (14% energy as carbohydrate [CHO< 50 g/day], 28%
protein [PRO], 58% fat [<10% saturated fat]) or an energy-
matched HC diet (53% CHO, 17% PRO, 30% fat [<10%
saturated fat]); combined with supervised aerobic/resistance
exercise (60minutes, 3 day/wk) for 12 months. Detailed
description of the diets, exercise program and the effects of
the dietary interventions on body weight, glycemic control, and
CVD risk factors have been reported elsewhere.2
Body Weight, Blood Pressure, HbA1c, Renal
Function Measures, and Protein Intake
Body weight was measured using calibrated electronic
scales (Mercury AMZ1, Tokyo, Japan) at baseline and monthly
intervals. Other outcomes were assessed at weeks 0, 24, and 52.
Seated blood pressure was measured by automated sphygmo-
manometry (SureSigns VS3; Phillips, Andover, MA). HbA1c
was measured at a certified pathology laboratory (Institute of
Medical and Veterinary Science Pathology, Adelaide, Austra-
lia). Outcomes were assessed in the clinic after an overnight
fast, with water consumed as required to avoid dehydration.
SCr was measured on a clinical analyzer (Beckman
AU480; Beckman Coulter, Inc., Brea, CA) using a standardized
assay (Beckman kit #OSR6178). eGFR (mL/min/1.73m2) was
calculated according to CKD-EPI Eq.3 which has greater
accuracy compared to the Modification of Diet in Renal Disease
(MDRD) equation at higher GFR (>60mL/min/1.73m2).4
Creatinine clearance (CrCl, mL/min) was estimated using the
Cockcroft–Gault equation5 with fat free mass (FFM—whole-
body dual-energy X-ray absorptiometry, Lunar Prodigy; Gen-
eral Electric Corporation, Madison, WI) adjustment to improve
estimation in obesity,6 and the Salazar–Corcoran Eq.7 devel-
oped for use in obese individuals based on estimated FFM.
AER, urinary albumin, and urea obtained from 24 hours urine
samples were measured at a certified commercial laboratory
(Institute of Medical and Veterinary Science Pathology, Ade-
laide, Australia).
Tay et alProtein intake (g/day) was estimated from 24 hours urinary
urea excretion at weeks 0, 24, and 52.8,9 Dietary compliancewas
assessed randomly from 7 consecutive days of daily weighed
2 | www.md-journal.comfood records for every 14-day period, analyzed using Food-
works Professional Edition Version 7 (Xyris Software 2012,
Highgate Hill, Australia). Both dietary patterns achieved a high
level of compliance as reported.2
Statistical Analyses
Baseline group differences were compared by independent
t tests and x2 tests for continuous and categorical variables,
respectively. AER and urinary albumin were reciprocally trans-
formed to improve normality before analysis. Comparisons of
changes over time between diets were analyzed by random-
coefficient analysis, restricted maximum likelihood, mixed
effects model using an unstructured covariance with data
assumed to be missing at random. The model included all
available data from participants who commenced the study
and contained the following fixed effects: main effect for each
time-point, diet group assignment, and diet group by time-point
interaction. The effect of the use of renin-angiotensin system
blocking agents including angiotensin-converting-enzyme
inhibitors and angiotensin receptor antagonists on the renal
outcomes investigated was examined in sensitivity analyses
that included this as a covariate. Estimated marginal means
(95% confidence intervals, CI) and change from weeks 0 to 52
are reported. Repeated measures ANOVAwith diet as between-
subjects factor and time as within-subject factor was used to
assess changes in dietary protein intake. All analyses were
performed using SPSS 20.0 for Windows (SPSS, Inc., Chicago,
IL); statistical tests were 2-tailed with statistical significance at
P< 0.05.
RESULTS
At baseline, there were no significant clinical or bio-
chemical differences between groups (Table 1). SCr and eGFR
were within the normal range (Table 2); 7 participants (LC:4,
HC:3) had moderately increased AER (30–300mg/24 h).10
Antihypertensive therapy use was similar in both groups
(LC:41, HC:35, P=0.29) with 56% of participants using
renin-angiotensin system blocking agents (LC:32, HC:32).
Sixty-eight percent of participants completed the study with
no difference between groups (LC:41/58, HC:37/57; P=0.51).
Over the 52 weeks, reductions in weight and blood pres-
sure were comparable between groups (P 0.18; Table 2). Nine
participants reduced (LC:4, HC:5) and 3 increased (LC:2,
HC:1) use of renin-angiotensin system blocking agents.
Self-reported protein intake was higher in LC compared to
HC (LC:106.1 18.9 g/d (26% energy), 1.2 g/kg/d; HC:78.5
14.8 g/d (18% energy), 0.9 g/kg/d), P< 0.001. Protein intakes
estimated from 24 hours urinary urea reflected similar differ-
ences (weeks 0, 24, and 52; LC: 112.1 34.3, 118.4 33.8,
120.1 38.2 g/d; 1.1 0.3, 1.4 0.4, 1.3 0.4 g/kg/d; HC:
107.7 28.4, 89.8 18.4, 95.8 27.8 g/d; 1.0 0.3, 1.0
0.2, 1.1 0.3 g/kg/d; P< 0.001).
Over time, SCr increased, while eGFR, CrCl, and AER
decreased, with no difference in the responses between groups
(Table 2). Sensitivity analyses that adjusted for the use of renin-
angiotensin system blocking agents did not alter the results of
the primary model. At baseline, 7 participants (LC:4, HC:3) had
pathological albuminuria (range 41–101mg/24 h). After 52
weeks, 4 of these participants (LC:2, HC:2) became normoal-
buminuric, 2 (LC:1, HC:1) remained pathologically albuminu-
Medicine  Volume 94, Number 47, November 2015ric, and 1 LC participant withdrew before week 52. All
participants who were normoalbuminuric at baseline remained
so after 52 weeks.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Baseline Participant Characteristics

LC Diet (n = 58) HC Diet (n = 57)
Demographics
Age 58 (7) 58 (7)
Sex [n (%)]
Females 21 (36) 28 (49)
Males 37 (64) 29 (51)
Duration of diabetes (years) 7 (5) 9 (7)
Body weight and BMI
Body weight (kg) 101.7 (14.4) 101.6 (15.8)
BMI (kg/m2) 34.2 (4.5) 35.1 (4.1)
Glycemic control
HbA1c (%) 7.3 (1.1) 7.4 (1.1)
CVD risk markers
SBP (mm Hg) 130.4 (13.1) 132.6 (13.2)
DBP (mm Hg) 80.0 (8.9) 80.8 (10.1)
Fasting insulin (mU/L)y 16.3 (8.3) 15.9 (7.6)
HOMA2-IRy 2.3 (1.1) 2.2 (1.0)
HOMA2-%By 75.5 (38.7) 67.7 (33.4)
Total Cholesterol (mmol/L) 4.5 (1.0) 4.3 (1.0)
LDL-C (mmol/L) 2.5 (0.9) 2.4 (0.9)
HDL-C (mmol/L) 1.2 (0.2) 1.3 (0.3)
TG (mmol/L) 1.6 (0.7) 1.4 (0.6)
Medications
[0,1-3] Diabetes medications
Insulin [n (%)] 6 (10) 6 (11)
Metformin [n (%)] 46 (79) 41 (72)
Sulfonylureas [n (%)] 20 (34) 16 (28)
Thiazolidinediones [n (%)] 3 (5) 3 (5)
GLP-1 agonists [n (%)] 1 (2) 1 (2)
DPP-4 inhibitors [n (%)] 1 (2) 2 (4)
Antihypertensive medications [n (%)] 41 (71) 35 (61)
ACE-inhibitors [n (%)] 20 (34) 19 (33)
Angiotensin-II receptor antagonists [n (%)] 14 (24) 13 (23)
Calcium channel blockers [n (%)] 18 (31) 12 (21)
Beta blockers [n (%)] 6 (10) 3 (5)
Lipid lowering medications [n (%)] 35 (60) 36 (63)
Data are means (SD), unless otherwise stated.
To convert mmol/L to mg/dL, multiply by 38.7 (for cholesterol) and 88.6 (for triglycerides).
ACE-inhibitors = angiotensin-converting-enzyme inhibitors; BMI= body mass index; DBP= diastolic blood pressure; DPP-4 inhibitors = dipepti-
dyl-peptidase-4 inhibitors; GLP-1 agonists = glucagon-like peptide-1 agonists; HC diet = high carbohydrate, low-fat diet; HDL-C= high density
lipoprotein cholesterol; HOMA2-%B=homeostasis model of assessment index 2-b cell function; HOMA2-IR=homeostasis model of assessment
index 2-insulin resistance; LC diet = very low carbohydrate, high protein/low saturated fat diet; LDL-C= low density lipoprotein cholesterol;
SBP= systolic blood pressure; TG= triglycerides.
Total analyzed n= 115 (LC:58, HC:57) for all data unless otherwise stated. All baseline characteristics were not significantly different between
diet groups (P> 0.05) by independent samples t test (continuous variables) or x2 test (categorical variables).
y ta;
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GFR and albuminuria are established indicators of the
presence and progression of DKD.10 This study showed these
markers responded similarly following consumption of either
energy-matched LC or HC weight-loss diets administered as
part of a holistic lifestyle modification program incorporating
regular exercise. The overall conclusion was not altered after
controlling for antihypertensive treatment.Within the limits of a
Total analyzed n = 103 (LC:52, HC:51) for insulin and HOMA2 da
analyses.modest sample size, our results in obese adults with T2DM, but
without overt DKD, confirm and extend the findings of previous
investigations conducted in people without diabetes and
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.individuals with preexisting DKD.11–14 The literature support-
ing the utility of protein restriction in slowing GFR decline or
delaying DKD progression is controversial. Acknowledging the
limitations of observational studies (such as the possibility of
unaccounted residual confounding), prospective cohort studies
of people with T2DM and without DKD at baseline have found
no association between protein intake and eGFR decline,15 or a
negative association between protein intake and risk of DKD.16
12 participants on insulin medication at baseline were excluded fromAlthough earlier meta-analyses have reported a small but
statistically significant reduction in GFR decline and incidence
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small number of people with diabetes (predominantly T1DM)
were studied and nonrandomized trials were included.17–19
Moreover a reduced risk of renal failure attributed to low
protein diets might reflect a delayed initiation of dialysis due
to amelioration of uremic symptoms rather than an actual
retardation of renal function decline. A recent meta-analysis
of randomized controlled trials showed that a low protein diet
was not associated with a significant improvement in renal
function in people with DKD when compared with a normal
protein diet (0.9 g/kg/day cf. 1.3 g/kg/day).20 The present study
did not specifically examine a low protein diet (0.8 g/kg/day,
16–18% total energy) recommended by current clinical guide-
lines for individuals with DKD.21 However, actual protein
intakes reported in low protein intervention groups have typi-
cally ranged from 0.7 to 1.1 g/kg/d19,20 which includes the mean
protein intake range of the comparison HC diet group in this
study (1–1.1 g/kg/d) that more likely reflects a typical protein
intake. Collectively, these data suggest that compared to a
traditional HC diet, consumption of an LC, high protein diet
(1.1–1.4 g/kg/d) derived from both plant and animal protein
sources, does not adversely affect renal function in individuals
with T2DM. This raises the clinical relevance of LC diets as a
tenable weight management strategy for individuals with
T2DM and comorbidities like hypertension and dyslipidemia,
to improve glycemic control and reduce CVD and diabetes
complications risk.2
Irrespective of any differences between the diets, both
groups experienced an overall reduction in eGFR and CrCl
despite substantial weight loss (9.1%), improvement in glyce-
mic control (HbA1c 1%, 10.9mmol/mol), reductions in
blood pressure (6/6mm Hg) and albuminuria.2 The 2% to
4% decrease in eGFR observed in the present study is compa-
tible with the expected age-related change in eGFR in
T2DM22,23 and is unlikely to be clinically significant. Previous
studies that reported declines in eGFR following weight loss
have examined individuals without renal impairment,11,14 com-
pared to those that reported increases in eGFR that examined
individuals with preexisting renal dysfunction.13,14 This
suggests that weight loss-induced increases in eGFR may more
likely occur in populations with preexisting renal dysfunction, a
phenomenon that has also been observed postbariatric
surgery.24 Moreover, the overall reduction in albuminuria over
time and the normalization of levels in patients with albumi-
nuria at baseline support the benefits of weight loss.25
A limitation of this study was that GFR was estimated
rather than directly measured. Clearance of inulin and radio-
isotope-labeled filtration markers (iGFR) are considered ‘‘gold
standards’’ for measuring GFR. Nevertheless, equations for
eGFR and CrCl are used widely in clinical practice for drug
dosing, screening, risk stratification and for monitoring DKD
progression. The equations used in this study have been vali-
dated in obese populations, including individuals with diabetes
and conferred greater accuracy compared with other equations
against iGFR.6 Hence, this methodological approach is con-
sidered appropriate for the purpose of comparing the long-term
renal effects of differing diet regimens.
Variations in determinants of creatinine generation (eg,
FFM, exercise, and diet) can also influence eGFR calculations.
The combined effect of a similar FFM loss (1.7 kg) and
increase in moderate to vigorous exercise2 could explain the
increase in SCr26 and consequent reductions in creatinine-based
Medicine  Volume 94, Number 47, November 2015eGFR calculations observed in both groups, potentially masking
any diet-induced differences in renal function. Changes in body
composition and the nonsteady-state clearance of endogenous
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.filtration markers expose the limitations of existing methods
and the complexity of assessing renal function after weight loss.
The use of combined creatinine-cystatin C equations may
improve precision by minimizing the influence of any particular
non-GFR determinant.27,28
In conclusion, a hypocaloric LC diet and an energy-
matched traditional HC diet had similar effects on markers
of renal function in people with T2DM without DKD over a 12-
month period. These results corroborate evidence that consump-
tion of an LC weight loss diet does not adversely affect renal
function in such populations. Longer-term follow-up studies are
required to determine whether these renal effects are sustained
during long-term weight loss maintenance and to establish if
long-term adherence to the diets results in differences in the
development and progression of DKD. Examining the effects of
LC diets in populations with preexisting vascular complications
besides nephropathy would further advance our understanding
of the utility of LC diets.
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